What are the recommended dosing regimens for doxepin for depression/anxiety, insomnia, and chronic urticaria, including dose adjustments for elderly patients and those with hepatic impairment, and what are the contraindications?

Doxepin Dosing

For depression/anxiety, start with 75 mg daily and titrate to 75-150 mg daily; for insomnia, use 3-6 mg nightly; for chronic urticaria, doxepin can be effective but carries significant drug interaction risks with other antihistamines. 1

Depression and Anxiety Dosing

Standard adult dosing: Begin with 75 mg daily for mild-to-moderate illness 1. The optimal therapeutic range is 75-150 mg daily, though severely ill patients may require gradual titration up to 300 mg daily. Doses exceeding 300 mg daily rarely provide additional benefit 1.

Dosing schedule flexibility: The total daily dose can be divided throughout the day or given as a single bedtime dose. However, when using once-daily dosing, the maximum recommended dose is 150 mg 1. The anti-anxiety effect appears before the antidepressant effect, with optimal antidepressant response typically requiring 2-3 weeks 1.

Patients with mild symptoms or emotional symptoms accompanying organic disease may respond to doses as low as 25-50 mg daily 1.

Insomnia Dosing

For insomnia, use low-dose doxepin: 3-6 mg nightly is the evidence-based range 2. This represents a fundamentally different dosing paradigm than depression treatment. Two high-quality RCTs demonstrated that doxepin 3 mg and 6 mg significantly improved wake time after sleep onset (WASO), total sleep time (TST), and sleep efficiency compared to placebo, with improvements sustained through 12 weeks 2. The 1 mg dose showed some efficacy but was less consistent 3, 4.

Key advantages at low doses: No next-day residual sedation, no memory impairment, no anticholinergic effects, and no weight gain were reported 3, 4. The efficacy is particularly notable for sleep maintenance and early morning awakenings—the primary sleep complaints in elderly patients 3.

Chronic Urticaria Dosing

Doxepin has antihistaminic properties but carries significant sedating and anticholinergic side effects 5. While it can be effective for difficult-to-treat chronic urticaria 6, critical contraindication: doxepin should NOT be taken concurrently with mizolastine or other drugs with arrhythmic potential 5. This is a major safety concern when combining with other urticaria treatments.

The British guidelines note doxepin's usefulness but emphasize its side-effect profile limits its role 5. One retrospective study from Turkey showed 75% response rate (44% complete response) in antihistamine-refractory patients, though specific dosing was not detailed 6.

Elderly Patient Adjustments

Start low in elderly patients: 10-20 mg daily for depression 7. A double-blind study demonstrated significant efficacy at these low doses (10-20 mg daily) without side effects in elderly rehabilitation patients 7.

Critical elderly considerations 1:

• Elderly patients are more susceptible to confusion and oversedation
• Start at the low end of dosing ranges
• Observe closely for anticholinergic effects (dry mouth, blurred vision, constipation, urinary retention)
• Greater frequency of decreased hepatic, renal, and cardiac function necessitates caution
• Once-daily dosing should be adjusted carefully based on patient condition

For insomnia in elderly: 1-3 mg nightly 3. The 12-week trial in elderly chronic insomnia patients showed sustained efficacy with excellent safety profiles at these doses 3.

Hepatic Impairment

The FDA label does not provide specific hepatic dosing adjustments 1. However, the British urticaria guidelines note that sedating antihistamines like doxepin should be avoided in severe liver disease because their sedating effect is inappropriate and may precipitate complications 5. Exercise extreme caution and consider significantly reduced doses or alternative agents in hepatic impairment.

Critical Contraindications and Warnings

Absolute contraindications:

• Concurrent use with MAO inhibitors
• Angle-closure glaucoma risk (pupillary dilation can trigger attacks in anatomically narrow angles) 1
• Concurrent use with mizolastine (when treating urticaria) due to arrhythmic potential 5

Black box warning: Increased suicidality risk in children, adolescents, and young adults with major depressive disorder 1. Doxepin is not recommended in children under 12 years 1.

Serious drug interactions:

• CYP2D6 inhibitors (e.g., clobazam) and CYP2C19 inhibitors (e.g., topiramate) can cause severe toxicity 8
• Poor CYP2D6 metabolizers have 8-fold higher plasma concentrations 1
• Chronic toxicity can present as confusion, ataxia, and seizures—potentially misdiagnosed as epilepsy 8

Cardiovascular monitoring: QRS prolongation is a significant indicator of toxicity 1. Obtain baseline ECG in high-risk patients.

Common Pitfalls to Avoid

1. Don't confuse depression dosing with insomnia dosing—they differ by 10-50 fold
2. Don't combine with other sedating medications in elderly without careful monitoring
3. Don't abruptly discontinue after prolonged use—taper gradually to avoid withdrawal symptoms 1
4. Don't overlook drug-drug interactions, particularly CYP2D6/2C19 inhibitors
5. Don't use the 150 mg capsule for treatment initiation—it's for maintenance only 1